FindTrial
Sign In

Patients perspectives on head and neck chemoradiation

Patients perspective on radiotherapy treatment decision in locally advanced [Stage III/IV] cancers of the head and neck - PORDLA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010712
Enrollment
30
Registered
2017-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Locally advanced [stage III/IV] cancers of the head and neck

Interventions

Intervention1: NIL: NIL

Sponsors

Tata Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Informed consent obtained Squamous cell carcimoma Non salivary gland primary Stage III/IV head and neck cancer patients - to be treated by CTRT

Exclusion criteria

Exclusion criteria: Previous radiotherapy Has had surgery first for the tumour Salivary gland tumour Is unable to read English, Bengali or Hindi. Patient is in such an emotional state that the treating oncologist feels taking part in the study will be detrimental to patientâ??s psychological health.

Design outcomes

Primary

MeasureTime frame
Patientâ??s perspective about optimal acceptable treatment.Timepoint: 3 time points: Pre-treatment, completion of treatment, 3 months post completion of treatment—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactSanjoy Chatterjee

Tata Medical centre

sanjoy.chatterjee@tmckolkata.com03366057402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026